Market Cap | 25.66K | P/E | - | EPS this Y | - | Ern Qtrly Grth | - |
Income | -199.1k | Forward P/E | - | EPS next Y | - | 50D Avg Chg | 6.00% |
Sales | 55.75k | PEG | - | EPS past 5Y | - | 200D Avg Chg | 7.00% |
Dividend | N/A | Price/Book | EPS next 5Y | - | 52W High Chg | -60.00% | |
Recommedations | - | Quick Ratio | 1.08 | Shares Outstanding | 4B | 52W Low Chg | 100.00% |
Insider Own | - | ROA | - | Shares Float | - | Beta | 7.24 |
Inst Own | - | ROE | - | Shares Shorted/Prior | -/- | Price | 0.00020 |
Gross Margin | 100.00% | Profit Margin | - | Avg. Volume | 5,550,306 | Target Price | - |
Oper. Margin | -350.44% | Earnings Date | - | Volume | 4,000,000 | Change | 0.00% |
International Consolidated Companies, Inc. develops and markets CBD products for the pet and animal markets. The company was formerly known as Sign Media Systems, Inc. and changed its name to International Consolidated Companies, Inc. in September 2007. The company was incorporated in 2002 and is based in Sarasota, Florida.